)
Generate Biomedicines (GENB) investor relations material
Generate Biomedicines Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Clinical-stage generative biology company leveraging AI-driven platform for protein drug design and development.
Platform integrates computational models and scalable biohardware to create differentiated therapeutics across multiple modalities and disease areas.
Lead product candidate, GB-0895, is a long-acting anti-TSLP monoclonal antibody in Phase 3 trials for severe asthma, with additional programs in COPD and oncology.
Business model includes internal pipeline development and strategic collaborations with major pharma partners (Amgen, Novartis).
Financial performance and metrics
No product sales to date; revenue derived from collaboration agreements with Amgen and Novartis.
2025 revenue: $31.9M (up from $20.5M in 2024), primarily from collaboration milestones.
Net loss for 2025: $223.0M; accumulated deficit as of December 31, 2025: $676.3M.
Cash, cash equivalents, and marketable securities as of December 31, 2025: $221.5M.
Pro forma net loss per share (2025): $(2.18); pro forma shares outstanding: 102.3M.
Use of proceeds and capital allocation
Estimated net proceeds from IPO: $368.8M (or $424.9M if underwriters' option exercised), assuming $16.00/share.
Proceeds to fund: (i) completion of two Phase 3 trials for GB-0895 in severe asthma, (ii) completion of Phase 1b and next phase for GB-0895 in COPD, (iii) platform and technology innovation, (iv) advancement of GB-4362 and GB-5267 through topline Phase 1 data, and (v) additional R&D and working capital.
Expected to fund operations into the first half of 2028.
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)